Kala Stapleton
Primary Care · Pennington Gap, VANPI 1912514209
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 151 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 21.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $933 and has fallen 67.8% since, to $300 in 2025.
Across 151 payments — averaging $15.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$500
- AbbVie$425
- Lilly USA, LLC$361
- Amgen$307
- GSK$147
- AstraZeneca$129
- plus $488 from 11 others
What the payments were for
- Food & beverage$2,357100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 39 | $500 |
| AbbVie | 23 | $425 |
| Lilly USA, LLC | 22 | $361 |
| Amgen(2 entities) | 23 | $307 |
| GSK | 10 | $147 |
| AstraZeneca | 8 | $129 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $109 |
| Biohaven Pharmaceuticals, Inc. | 4 | $92 |
| Amarin Pharma, Inc. | 5 | $75 |
| Pfizer | 3 | $61 |
| Novartis | 2 | $37 |
| Phathom Pharmaceuticals, Inc. | 1 | $26 |
| Astellas Pharma US Inc | 1 | $20 |
| Boehringer Ingelheim | 1 | $19 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $16 |
How this compares
$2,357 in reported general payments places this provider in the 80th percentile of 142 primary care providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 69 | $106,626 |
| OzempicSemaglutide | 57 | $74,399 |
| EliquisApixaban | 49 | $55,049 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 23 | $15,057 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 14 | $15,016 |
| Aimovig AutoinjectorErenumab-Aooe | 17 | $13,178 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 12 | $5,720 |
| SavellaMilnacipran Hcl | 11 | $5,397 |
| Advair HfaFluticasone Propion/Salmeterol | 11 | $4,869 |
| Dexlansoprazole DrDexlansoprazole | 16 | $3,520 |
| PremproEstrogen,con/M-Progest Acet | 13 | $3,161 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 60 | $2,540 |
| Omeprazole | 115 | $2,507 |
| Diclofenac Sodium | 64 | $1,963 |
| Cefdinir | 83 | $1,714 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $361 | $106,62669 claims |
| Novo NordiskOzempic | $500 | $74,39957 claims |
| PfizerEliquis, Prempro | $61 | $58,21062 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $147 | $20,77735 claims |
| AstraZenecaBreztri Aerosphere | $129 | $15,01614 claims |
| AbbVieSavella, Synthroid | $425 | $7,02433 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 142 primary care providers in Virginia.
Other primary care in Pennington Gap
- Rebecca GrinsellRichmond$12K
- Jennifer CampbellNewport News$8K
- Tien MaAnnandale$7K
- Michael CogginAshland$7K
- Erin StewartFredericksburg$6K
- Lawanda WoodNorfolk$6K
- Sara WeaverDanville$5K
- Luis Rivera PenaFalls Church$4K
- Erika RobinsonFredericksburg$4K
- Haley SwansonVirginia Beach$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.